期刊文献+

多层螺旋CT对进展期乳腺癌新辅助化疗的疗效评估 被引量:9

The efficacy of CT in the evaluation of the neoadjuvant chemotherapy in patients with primary breast cancer
下载PDF
导出
摘要 目的探讨多层螺旋CT在乳腺癌新辅助化疗疗效评价中的应用价值,以求进一步明确螺旋CT对乳腺癌新辅助化疗疗效的预测评估。方法 25例初治原发性乳腺癌患者,均为女性,年龄33~62岁,平均年龄48.9岁,全组病例化疗前行粗针穿刺明确诊断,分别行2~4周期新辅助化疗,新辅助化疗前后行螺旋CT扫描,测量化疗前后肿块数目及大小、淋巴结数目及大小、肿块强化模式等。结果多层螺旋CT检查评价乳腺癌病灶变化与病理学评价的符合率90.9%。结论多层螺旋CT结合三维重建技术能够准确反映出乳腺癌病灶及淋巴结化疗前后的信息,并能准确的反映乳腺癌病灶化疗前后的血流信息,对预测乳腺癌新辅助化疗疗效具有一定的应用价值。 Objective To investigate the value of CT of breast cancer in evaluation of therapeutic effect of neoadjuvant chemotherapy. Methods 25 patients with primary breast cancers were women, ranging from 33 to 62 years of age, with a mean age of 48.9 years. All patients underwent the core needle biopsy and confirmed diagnosis before neoadjuvant therapy. Treatment course was 2-4 periods. CT was examined before and after neoadjuvant therapy. The tumor number and size, lymph node number and size, enhancement mode were measured before and after neoadjuvant therapy. Results According to the length of breast mass lesion, the accuracy for CT in evaluating effect of neoadjuvant chemotherapy was 90.9%. Conclusion CT combined with 3D reconstruction technique can reflect the mass and lymph node information before and after neoadjuvant therapy, and can also reflect the blood flow information of the mass. It was useful to forecast the effect of neoadjuvant chemotherapy of breast cancer.
出处 《医学影像学杂志》 2012年第10期1677-1680,共4页 Journal of Medical Imaging
基金 浙江省医药卫生科学研究基金项目计划(2004B209) 丽水市科技局科技计划项目(2010JYZB23)
关键词 乳腺肿瘤 新辅助化疗 体层摄影术 X线计算机 Breast cancer Neoadjuvant chemotherapy CT Tomography, X-ray computed
  • 相关文献

参考文献11

  • 1陈丽荣.乳腺癌新辅助化疗的临床意义和病理学评价[J].中华病理学杂志,2010,39(4):218-221. 被引量:17
  • 2Ogston KN, Miller ID, Payne S, et al. A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival[J]. Breast, 2003, 2: 320-327. 被引量:1
  • 3Martincich I., Montemurro F, De Rosa G, et al. Monitoring response to primary chemotherapy in breast cancer using dy namic contrast-enhanced magnetic resonance imaging [J]. Breast Cancer Res Treat, 2004, 83: 67-76. 被引量:1
  • 4Suzuki C, Jacobsson H, Hatschek T, et al. Radiologic meas- urements of tumor response to treatment lpractica] approa- ches and limitations [J]. Radiographics, 2008, 28: 329-344. 被引量:1
  • 5Kaufmann M, Hoflobagyi GN, Goldhirsch A, et al. Neoad- juvant chemotherapy of breast cancer [J]. J Clin Oncol, 2006, 24: 1940-1949. 被引量:1
  • 6Kuerer HM, Singletary SE, Buzdar AU, et al. Surgical con- servation palnning after neoadjuvant chemotherapy for stage II and operable atage III Breast caicinoma [J]. Am J Surg,2003, 182:601-608. 被引量:1
  • 7刘庆仪,任洪文,王尊,李少英,黄小云,孙爱静.新辅助化疗在局部进展期乳腺癌保乳治疗中的临床价值[J].中国肿瘤临床,2010,37(13):753-756. 被引量:13
  • 8Zangheri B, Messa C, Picchio M, et al. PET/CT and breast cancer[J].EurJ NucI Med Mol Imaging, 2004, 31: 36-42. 被引量:1
  • 9Tozaki M, Uno S, Kobayashi T, et al. Histologic breast cancer extent after neoadjuvant chemotherapy: comparison with multideteetor-row CT and dynamic MRI[J].Radiat Med, 2004, 22: 246-253. 被引量:1
  • 10王丰富,戚洪波,徐启怀,徐晓剑.多层螺旋CT乳腺检查方法与应用价值探讨[J].医学影像学杂志,2007,17(3):266-268. 被引量:7

二级参考文献45

  • 1张静,田建明.乳腺癌的影像学检查[J].医学影像学杂志,2004,14(9):767-769. 被引量:17
  • 2刘宏军,沈丹华,刘鹏,王殊,曹迎明,周波,佟富中,杨德启,乔新民,张嘉庆.新辅助化疗后乳腺癌的临床病理学改变[J].中国妇产科临床杂志,2005,6(1):44-47. 被引量:11
  • 3宋艳利,王东.新辅助化疗对Ⅱ期乳腺癌的疗效观察[J].中国肿瘤临床,2007,34(7):411-412. 被引量:7
  • 4Estévez LG,Gradishar WJ.Evidence-based use of neoadjuvant taxane in operable and inoperable breast cancer.Clin Cancer Res,2004,10(10):3249-3261. 被引量:1
  • 5Fisher B,Brown A,Mamounas E,at al.Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer:findings from National Surgical Adjuvant Breast and Bowel Project B-18.J Clin Oncol,1997,15(7):2483-2493. 被引量:1
  • 6Fisher B,Bryant J,Wolmark N,et al.Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.J Clin Oncol,1998,16(8):2672-2685. 被引量:1
  • 7Kimmick GG,Cirrincione C,Duggan DB,et al.Fifteen-year median follow-up results after neoadjuvant doxorubiein,followed by mastectomy,followed by adjuvant cyclophosphamide,methotrexate,and fluorouracil(CMF)followed by radiation for stage Ⅲ breast cancer:a phase Ⅱ trial(CALGB 8944).Breast Cancer Res Treat,2009,113(3):479-490. 被引量:1
  • 8Cariati M,Purushotham AD.Stem cells and breast cancer.Histopathology,2008,52(1):99-107. 被引量:1
  • 9Kurosumi M,Takatsuka Y,Watanabe T,et al.Histopathological assessment of anastrozle and tamoxifen as preoperative(neoadjuvant)treatment in postmenopausal Japanese women with hormone receptor-positive breast cancer in the PBOACT trial.J Cancer Res Clin Oncol,2008,134(6):715-722. 被引量:1
  • 10Thomas JS,Julian HS,Green BY,et al.Histopathology of braest carcinoma following neoadjuvant systemic therapy:a common association between letrozole therapy and central scarring.Histopathology,2007,51(2):219-226. 被引量:1

共引文献35

同被引文献131

引证文献9

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部